How pharmaceutical companies profit from drugs for rare diseases – The Conversation UK


The Conversation UK
How pharmaceutical companies profit from drugs for rare diseases
The Conversation UK
Dyfrig Hughes is member of the All Wales Medicines Strategy Group, and has acted as external expert for the Committee of Orphan Medicinal Products in the EU …
Pharmaceutical companies are profiting from rare diseases …EurekAlert (press release)

all 3 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd